1.
Falchi L, Baron JM, Orlikowski CA, Ferrajoli A. BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Mediterr J Hematol Infect Dis [Internet]. 2016Feb.10 [cited 2020Jul.5];80:e2016011. Available from: http://mjhid.org/index.php/mjhid/article/view/2016.011